Cost of multidrug resistant tuberculosis in Germany—An update

Cost of multidrug resistant tuberculosis in Germany—An update

Background: In 2019, new therapeutic recommendations for multidrug-resistant (MDR-) and extensively drug-resistant (XDR) tuberculosis (TB) were published by the WHO, advocating the use of oral drugs and stepwise composition of antibiotic regimens. To date, the economic consequences of those recommen...

Full description

Bibliographic Details
Main Authors: R. Diel, G. Sotgiu, S. Andres, D. Hillemann, F.P. Maurer
Format: Article
Language:English
Published: Elsevier 2021-02-01
Series:International Journal of Infectious Diseases
Subjects:
Cost analysis
Monte Carlo simulation
Tuberculosis
MDR-TB
XDR-TB
Antimicrobial resistance
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971220322876

Internet

http://www.sciencedirect.com/science/article/pii/S1201971220322876

Similar Items